← FDA DRUG APPROVALS

FDA ANDA · ANDA201072

DEXMEDETOMIDINE HYDROCHLORIDE

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA201072
TYPE
ANDA
ORIGINAL APPROVAL
2015-09-18
LATEST ACTION
2023-11-28
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

DEXMEDETOMIDINE HYDROCHLORIDEPrescription
DEXMEDETOMIDINE HYDROCHLORIDE EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) · INJECTABLE · INJECTION

Approval history

2023-11-28Labeling · Supplement 8 · standardAP
2020-06-16Labeling · Supplement 2 · standardAP
2020-06-16Labeling · Supplement 1 · standardAP
2015-09-18Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →